Latest News: 21 April 2025 TROG Cancer Research is among 70 research bodies in Australia that are supporting a national initiative to make existing health and medical research data easier to find, boosting secondary use of valuable clinical trials research data. The Health Studies Australian National Data Asset (HeSANDA)
INTERVIEW: 9 April 2025 Professor Bryan Burmeister is one of TROG’s longest standing members, who has contributed to our work in a myriad of ways over the past 30 years. He was TROG Scientific Committee Chair from 2002-2007, Board President from 2007 to 2010 and has led multiple trials.
Latest news: 28 March 2025. TROG Members who have made significant contributions both to the work of TROG and to advancing radiation medicine clinical trial research more broadly were recognised with our 2025 Research Excellence Awards this month. We congratulate the following winners on their well-deserved awards, which were
9 January 2025: Two important TROG Cancer Research trials investigating liver cancer and brain metastases resulting from other advanced cancers are set to progress to the next level, after successfully gaining a total of $250,000 in grants from the Tour de Cure cancer charity. Tackling hepatocellular cancer The TROG
7 January 2025: TROG Cancer Research is advancing vital cancer research, with the support of a generous $300,000 donation from the GenesisCare Foundation. The donation will support TROG’s work to promote the prevention and control of cancer through cancer research, in line with our objectives, mission and strategic goals
28 November 2024: In this Q&A, TROG President A/Prof Puma Sundaresan talks about her passion for patient-centred cancer care, her vision for TROG and future directions for radiation medicine research. Q: What attracted you to the field of radiation oncology, and drives your continued passion for this field? A:
23 October 2024: TROG Cancer Research is thrilled to be among 14 clinical trial groups awarded new Cancer Australia funding with a combined total of almost $22.2 million to support vital work in improving cancer care and outcomes. Minister for Health and Aged Care, the Hon Mark Butler MP,
15 October 2024: TROG Cancer Research has made a commitment to embracing the principles of diversity, equity and inclusion (DEI) across all aspects of our work, with the launch of a new DEI policy. The Diversity, Equity and Inclusion (DEI) Policy provides guidelines to ensure DEI principles are embedded
12 September 2024: TROG Cancer Research has outlined how it plans to further the organisation’s vital work advancing and diversifying radiation medicine research over the next three years. The TROG Cancer Research Strategic Plan 2024-2026 outlines our strategic priorities, key initiatives that will be undertaken over the three-year-period, and
The 2023 TROG Cancer Research Annual Report details achievements including strengthened collaborations and growth in membership.
For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.
Latest News
Keep up to date with TROG news, subscribe to our community newsletter.
ABN: 45 132 672 292
